Patient engagement study for untreated keratoconus
Part of Eyes & vision clinical trials.
This trial is looking at what it's like for people with keratoconus who have not yet had any treatment. It helps researchers understand how to better include patients in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have keratoconus and have never been treated for it
- You are able to give your written permission to join the study
- If you can become pregnant, you must have a negative pregnancy test and not be breastfeeding
- You are not currently taking part in any other study treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a surgery called CTAK for people with keratoconus or corneal ectasia. It aims to see if the surgery can help improve vision by reshaping the cornea.
This study looks at what leads to keratoconus and how it progresses over time. It may help doctors better predict worsening vision and plan earlier care.
This study follows people with keratoconus—a condition where the cornea (clear front part of the eye) thins and bulges into a cone shape—or early signs of it. Researchers will track corneal changes over time to better understand and detect the disease early.
This study looks at how common certain eye conditions are in children and teens who are visiting a clinic for a reason unrelated to eye problems. It may help doctors understand how often these issues occur and plan better screening and care.
This trial is for people who have keratoconus (a cornea condition that can blur vision). It involves receiving care or evaluation at the Homburg Keratoconus Center, and it may help by improving how keratoconus patients are managed.
This study uses a special eye scan (anterior segment OCT) to map the cornea's surface and help detect keratoconus at an early stage. It aims to improve diagnosis for people with suspicious or mild signs of the condition.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.